We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
801
Viridian Therapeutics
VRDN
$2.19B
$6.56M 0.01%
301,289
-661,204
-69% -$10.4M
NCLH icon
802
Norwegian Cruise Line
NCLH
$8.95B
$6.55M 0.01%
327,089
-541,240
-62% -$8.68M
CHEF icon
803
Chefs' Warehouse
CHEF
$3.86B
$6.5M 0.01%
220,952
-52,698
-19% -$1.27M
SLAMW
804
CALL
DELISTED
Slam Corp. warrant
SLAMW
$6.5M 0.01%
599,444
-19,840
-3% -$2.47K
SNA icon
805
Snap-on
SNA
$20.9B
$6.49M 0.01%
22,453
-51,432
-70% -$13.9M
PM icon
806
CALL
Philip Morris
PM
$305B
$6.47M 0.01%
+68,800
New +$6.34M
SLB icon
807
SLB Ltd
SLB
$77.7B
$6.44M 0.01%
+123,759
New +$6.73M
FOXF icon
808
Fox Factory Holding Corp
FOXF
$783M
$6.41M 0.01%
+95,021
New +$6.93M
XYL icon
809
Xylem
XYL
$28.6B
$6.4M 0.01%
55,977
-8,187
-13% -$817K
CCCC icon
810
C4 Therapeutics
CCCC
$398M
$6.35M 0.01%
+1,123,061
New +$2.56M
ARES icon
811
Ares Management
ARES
$28.7B
$6.23M 0.01%
52,373
+5,905
+13% +$641K
SLV icon
812
PUT
iShares Silver Trust
SLV
$28.2B
$6.22M 0.01%
285,800
-415,400
-59% -$8.84M
HESM icon
813
Hess Midstream
HESM
$5.15B
$6.22M 0.01%
196,628
-648,820
-77% -$19.9M
GCT icon
814
GigaCloud Technology
GCT
$1.44B
$6.2M 0.01%
+338,860
New +$3.73M
MODV
815
DELISTED
ModivCare
MODV
$6.2M 0.01%
140,903
+27,215
+24% +$1.07M
KBE icon
816
CALL
State Street SPDR S&P Bank ETF
KBE
$1.63B
$6.19M 0.01%
+134,600
New +$5.33M
ETNB
817
DELISTED
89bio
ETNB
$6.19M 0.01%
554,337
-616,419
-53% -$5.67M
ICUI icon
818
ICU Medical
ICUI
$4.01B
$6.18M 0.01%
+61,948
New +$6.06M
GS icon
819
CALL
Goldman Sachs
GS
$306B
$6.17M 0.01%
16,000
+9,800
+158% +$3.27M
REVG
820
DELISTED
REV Group
REVG
$6.15M 0.01%
338,606
+43,102
+15% +$690K
ON icon
821
ON Semiconductor
ON
$33.8B
$6.14M 0.01%
73,546
-31,229
-30% -$2.45M
SPG icon
822
Simon Property Group
SPG
$74.7B
$6.13M 0.01%
43,001
-165,243
-79% -$20M
SVV icon
823
Savers
SVV
$1.46B
$6.12M 0.01%
352,027
+321,448
+1,051% +$4.86M
ENR icon
824
Energizer
ENR
$1.45B
$6.11M 0.01%
+192,899
New +$6.11M
BRZE icon
825
Braze
BRZE
$2.72B
$6.11M 0.01%
+114,918
New +$5.68M

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.